Type of antibody test used in the study at uncLabCorp’s Cov2Quant™ IgG test, which is available only for use in clinical trials and research, was developed to specifically detect and quantify antibodies to SARS-CoV-2, the virus that causes COVID-19. The level of antibodies is an important indicator of the strength of a person’s immune response, which can help determine the effectiveness of vaccines and therapies. Other COVID-19 antibody tests available in the market are qualitative and detect the presence of antibodies, but do not provide information on the individual’s antibody levels.
No, I wasn't given any information on that - the one study I am part of is specifically for persons with IBD, while the other I believe is just for vaccine response in general.I did speak with a company here which runs the spike antibody test (for natural and/or vaccine antibodies) but they have a warning that results may be skewed with immune-compromised patients. Were you, or Lisa, given any info regarding this?
The test available here does give a value, rather than just a positive/negative result (thanks Lisa for bringing this up).